RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Baxter International Inc.

A collection of news and information related to Baxter International Inc. published by this site and its partners.

Top Baxter International Inc. Articles see all

Displaying items 1-5
  • Baxter buys drug company with sickle cell treatment

    Baxter buys drug company with sickle cell treatment
    Baxter International Inc. said Wednesday it has acquired AesRx LLC, a small Massachusetts-based pharmaceutical firm focused on orphan drug treatments, for an undisclosed amount.
  • Abbott, AbbVie part of red-hot pharmaceutical deal market

     Abbott, AbbVie part of red-hot pharmaceutical deal market
    AbbVie Inc. appears to be on the verge of a $53.7 billion takeover that would change its corporate address to the United Kingdom. Abbott Laboratories agreed Monday to sell part of its generic drug business for $5.3 billion, structuring the sale in a way...

    Baxter revenue climbs, but earnings drop on charges

     Baxter revenue climbs, but earnings drop on charges
    Baxter International Inc.'s second-quarter profit fell 11.8 percent to $520 million as a variety of one-time charges dragged down its bottom line. Revenue in the quarter grew 16.1 percent to $4.3 billion, driven largely by contributions from its...

    Baxter beats expectations on higher sales

    Baxter beats expectations on higher sales
    Baxter International Inc. on Monday reported better-than-expected income and revenue for the fourth quarter as demand for its hemophilia and dialysis products boosted sales. The Deerfield-based medical products company said net income fell 34 percent to...

    Rezko gavel-to-gavel: Week 2

    Rezko rewind. Day 8 March 14, 2008; 5:13 a.m. A hospital lobbyist testified at the Tony Rezko corruption trial that he feared the friend and fundraiser of Gov. Rod Blagojevich would turn a hospital regulatory board against his clients. So Jeff Ladd, the...